Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes

Drug-induced liver injury (DILI) is an adverse toxic hepatic clinical reaction associated to the administration of a drug that can occur both at early clinical stages of drug development, as well after normal clinical usage of approved drugs. Because of its unpredictability and clinical relevance, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Quintás, Guillermo, Martínez-Sena, Teresa, Conde, Isabel, Pareja Ibars, Eugenia, Kleinjans, Jos, Castell, José V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Toxicogenomics and Omics Technologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380240/
https://www.ncbi.nlm.nih.gov/pubmed/34274980
http://dx.doi.org/10.1007/s00204-021-03114-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380240/
https://www.ncbi.nlm.nih.gov/pubmed/34274980
http://dx.doi.org/10.1007/s00204-021-03114-z

Ejemplares similares